{"id":"W4417001876","doi":"10.1182/blood-2025-8120","title":"Quality initiative in first-line multiple myeloma assessing the use of anti-CD38 agents and quadruplet therapy","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Multiple myeloma; Carfilzomib; Bortezomib; Guideline; Daratumumab; Cancer; Thalidomide; Transplantation; Ixazomib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01216556,0.0002244675,0.0005006653,0.002495403,0.0003191491,0.001198807,0.0008756412,0.000307259,0.001658631],"category_scores_gemma":[0.02766473,0.0001890165,0.0009357036,0.0057683,0.0003013033,0.0007368013,0.001207744,0.0007030389,0.0001973425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003560885,"about_ca_system_score_gemma":0.002560558,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01621352,"about_ca_topic_score_gemma":0.01227782,"domain_scores_codex":[0.9868846,0.00459126,0.002615273,0.001355274,0.003981453,0.0005720946],"domain_scores_gemma":[0.9254421,0.01008653,0.05396998,0.001129781,0.007219787,0.002151869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004416943,0.0000769585,0.9921131,0.0001701276,0.0002761554,0.00001249234,0.00005066163,0.0003634599,0.00003623525,0.00006405354,0.001424427,0.004970699],"study_design_scores_gemma":[0.00008272701,0.000373004,0.9959124,0.00008325142,0.0001190421,0.00007735097,0.00007897209,0.001172342,0.0001555138,0.00004377229,0.001893918,0.000007736487],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9453039,0.004442343,0.0021259,0.001118965,0.00005086136,0.0008905555,0.04135038,0.0000878854,0.004629143],"genre_scores_gemma":[0.9796008,0.0004068076,0.001830561,0.0002783887,0.00004188164,0.0004569296,0.0170691,0.00001231575,0.0003032057],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01621352,"threshold_uncertainty_score":0.06433839,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1723856898639533,"score_gpt":0.4084972379578981,"score_spread":0.2361115480939447,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}